CAMP-SIGNALING PATHWAY ACTS IN SELECTIVE SYNERGISM WITH GLUCOSE OR TOLBUTAMIDE TO INCREASE CYTOSOLIC CA2-CELLS( IN RAT PANCREATIC BETA)

Citation
K. Yaekura et al., CAMP-SIGNALING PATHWAY ACTS IN SELECTIVE SYNERGISM WITH GLUCOSE OR TOLBUTAMIDE TO INCREASE CYTOSOLIC CA2-CELLS( IN RAT PANCREATIC BETA), Diabetes, 45(3), 1996, pp. 295-301
Citations number
39
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
ISSN journal
00121797
Volume
45
Issue
3
Year of publication
1996
Pages
295 - 301
Database
ISI
SICI code
0012-1797(1996)45:3<295:CPAISS>2.0.ZU;2-C
Abstract
cAMP and the insulinotropic peptides that raise cAMP glucose-dependent ly increase the cytosolic free Ca2+ concentration ([Ca2+](i)) in pancr eatic beta-cells, which is tightly linked to the potentiation of gluco se-induced insulin release. me examined whether cAMP increases [Ca2+]( i) in specific cooperation only with glucose or also with other insuli n secretagogues that act through different mechanisms. [Ca2+](i) in si ngle rat pancreatic beta-cells was measured by dual-wavelength fura-2 microfluorometry. In the presence of a stimulatory concentration of gl ucose (8.3 mmol/l) and the moderate elevation in [Ca2+](i) induced by it, forskolin, an activator of adenylyl cyclase, or dibutyryl cAMP pro duced a marked additional increase in [Ca2(+)](i) but was ineffective at the basal 2.8 mmol/l glucose. These cAMP-elevating agents also pote ntiated the effect of tolbutamide on [Ca2+](i). The cAMP-induced incre ase in [Ca2+](i) was completely and selectively inhibited by a blocker of cAMP-dependent protein kinase A (PKA), and by nitrendipine, a bloc ker of the L-type Ca2+ channel. However, in the presence of high KCl a nd the [Ca2+](i) elevation induced by it, a rise in cAMP failed to fur ther increase [Ca2+](i), whereas BAY K8644, an agonist of L-type Ca2channels, evoked an additional increase in [Ca2+](i). Under low Na+ co nditions, the [Ca2+](i) response to cAMP was observed in the majority of the cells. In the cells in which glucose at 4.5-5 mmol/l was inadeq uate to increase [Ca2+](i), the glucose together with a rise in cAMP o ften increased [Ca2+](i). Likewise, tolbutamide and a rise in cAMP act ed in concert to increase [Ca2+](i). Thus, cAMP left-shifted the conce ntration-[Ca2+](i) response relationship for glucose and tolbutamide. In conclusion, the cAMP-PKA pathway acts in selective synergism with g lucose and tolbutamide to initiate [Ca2+](i) signals in pancreatic bet a-cells. cAMP appears to regulate beta-cell sensitivity to glucose and tolbutamide. In contrast, cAMP fails to cooperate with high KCl to in crease [Ca2+](i). It is suggested that cAMP acts mainly on a site that is more proximal but functionally linked to the L-type Ca2+ channel, thereby finally increasing Ca2+ flux through this channel.